钙化周径、厚度与长度对经颈动脉血运重建早期和晚期结局的影响
本研究回顾性分析了304例(313次手术)接受经颈动脉血运重建(TCAR)患者的前瞻性登记数据,通过术前CTA评估钙化周径百分比、最大厚度和长度。结果显示钙负荷各指标与30天卒中/死亡、晚期卒中/死亡及再狭窄率均无显著相关,Kaplan-Meier分析亦显示不同钙化分级组间1、2、3年无事件生存率相似。
要点
- TCAR术后30天总体卒中率为2.0%,卒中/死亡/心肌梗死复合率为3.5%。
- 钙化厚度、长度及周径各分组间早期和晚期卒中、再狭窄率均无显著差异。
核心结论
- 钙负荷(周径百分比、厚度、长度)对TCAR早期和晚期临床结局无显著影响。
研究设计与样本
- 回顾性分析前瞻性收集的TCAR监测项目(SVS/VQI)中304例患者(313次手术)数据,平均年龄71岁,平均随访29.4个月(范围1-108个月)。
- 术前CTA评估三项钙化变量:周径钙化程度(0至<25%、≥25%至<50%、≥50%至<75%、≥75%)、最大钙化厚度(mm)和钙化长度(mm)。
- 主要结局为30天围手术期卒中/死亡率,次要结局包括30天卒中、死亡和心肌梗死复合率,晚期结局包括卒中/死亡率和晚期支架内再狭窄(>50%或>80%)。
主要发现
- 30天围手术期总体卒中率为2.0%,卒中/死亡/心肌梗死率为3.5%。
- Kaplan-Meier分析显示,根据钙化周径、厚度和长度分组的1年、2年和3年无卒中、无卒中/死亡及无≥50%再狭窄率相似。
临床怎么用
- 对于接受TCAR的重度钙化病变患者,钙负荷各参数未显示增加早期或晚期不良事件风险,但需结合个体化评估。
局限性
- 回顾性研究设计,样本来自单一中心,可能存在选择偏倚。
- 钙化评估基于术前CTA,测量方法可能存在观察者间差异。
- 随访时间有限,部分亚组事件数较少,统计效能可能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcarotid artery revascularizationTCAR) has been proposed as an alternative for both transfemoral carotid artery stenting and carotid endarterectomy. Transfemoral carotid artery stenting has been associated with increased risk in heavily calcified lesions. Therefore, this study analyzed the effect of calcium burden (percentage of circumference calcification, thickness, and/or length) on TCAR early and late clinical outcomes. METHODS: This retrospective review prospectively collected data from patients who underwent TCAR and were enrolled in the TCAR Surveillance Project (Society for Vascular Surgery/Vascular Quality Initiative) at our institution. Preoperative computed tomography angiographies were reviewed to determine three calcium variables: (1) degree of circumferential calcification, classified into 0 to <25%, ≥25% to <50%, ≥50% to <75%, and ≥75%; (2) calcification thickness in millimeters (measured as the greatest thickness); and (3) lesion calcification length in millimeters. The primary outcome was 30-day perioperative stroke/death rate, and the secondary outcomes included the combined 30-day stroke, death, and myocardial infarction rate. Late outcomes included the stroke/death rate and late in-stent restenosis (>50% or >80%). A Kaplan-Meier analysis was used to estimate freedom of stroke, stroke and death, and ≥50% restenosis rates according to calcium classification. RESULTS: This study analyzed 304 patients (313 procedures) with a mean age of 71 years and mean follow-up of 29.4 months (range, 1-108 months). Circumference calcification were 0% to 25% in 37%, 26% to 50% in 24%, 51% to75% in 18%, and >75% in 20% (0%-50% in 62% and 51%-100% in 38%). Calcification thickness of ≤1 mm was noted in 22%, 1 to 2 mm in 27%, 2 to 3 mm in 26%, 3 to 4 mm in 18%, and >4 mm in 7% (<2 mm in 49% and ≥2 mm in 51%), and a calcification length of <5 mm in 10%, 5 to <10 mm in 4%, 10 to <15 mm in 15%, 15 to <20 mm in 20%, 20 to <25 mm in 26%, and ≥25 mm in 24% (<20 mm in 50%, and ≥20 mm in 50%). The overall 30-day perioperative stroke rate was 2.0% and stroke/death/myocardial infarction of 3.5%. The 30-day perioperative stroke rate according to calcium circumference (<50% vs ≥50%) was 1.7% vs 2.9% (P = .674); length (<20 mm vs ≥20 mm) was 2.1% vs 2.2% (P = 1); and thickness (<2 mm vs ≥2 mm) was 1.5% vs 2.9% (P = .6841). Stroke rates (early and late) stratified between those with a calcium circumference of <50% vs ≥50% were 4.2% vs 4.9% (P = .771); in those with a length of <20 mm vs ≥20 mm, rates were 6% vs 3% (P = .242); and in those with a thickness of <2 mm vs ≥2 mm, rates were 3.8% vs 5.2% (P = .599). Rates for >50% restenosis for calcium circumference (<50% vs ≥50%) were 7.9% vs 8.8% (P = .821); length (<20 mm vs ≥20 mm) were 7.5% vs 9.0% (P = .663); and thickness (<2 mm vs ≥2 mm) were 7.6% vs 8.8% (P = .825). Kaplan-Meier analysis showed that the rates of freedom from stroke, stroke and death, and ≥50% restenosis at 1, 2, and 3 years according to calcification circumference, thickness, and length were similar. CONCLUSIONS: This study showed no significant effect of calcium burden on TCAR early and late outcomes.
引用
- AbuRahma A, Dargy N, Santini A, et al. The effect of calcium circumference, thickness, and length on the early and late outcomes of transcarotid artery revascularization. J Vasc Surg. 2026. PMID: 41786005. doi:10.1016/j.jvs.2026.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。